Authors
Loading...
Randomized trial assesses misclassification in clinical diagnosis of Parkinson disease, suggesting the need for better biomarkers.
Rizzo et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: